◆英語タイトル:Eunice Kennedy Shriver National Institute of Child Health and Human Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014392
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the fields of fields of reducing infant deaths, improving health of women, men and families learning. It offers research in clinical trials and clinical research, health education campaigns and programs, NICHD publications, scientific research planning and scientific resources. NICHD also provides funding support for training and career development activities at universities and other institutions. The institute offers its services for laboratory research, clinical trials and studies. NICHD is headquartered in Rockville, Maryland, the US.
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cyprium Therapeutics Enters into Research and Development Agreement with Eunice Kennedy Shriver NICHD 10
SRI International Enters into Biological Testing Facility Contract with NICHD 11
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 12
Licensing Agreements 13
NICHD Enters into Licensing Agreement with Cyprium Therapeutics 13
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Key Competitors 14
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Key Employees 15
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Research And Development 17
Jan 06, 2017: Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases 17
Government and Public Interest 18
Nov 13, 2017: Obesity during pregnancy may lead directly to fetal overgrowth, NIH study suggests 18
Oct 24, 2016: Federal agencies express support for updated safe infant sleep recommendations 19
Sep 26, 2016: NIH Funds Research Network Focused on HIV-Infected Youth 20
Mar 21, 2016: Giving antibodies to infant macaques exposed to an HIV-like virus could clear the infection 21
Feb 18, 2016: NIH-supported trials test hormonal therapy in older men with low testosterone levels 23
Feb 04, 2016: Using Steroids Before Late Preterm Delivery Reduces Neonatal Respiratory Problems 24
Jan 04, 2016: Infertility treatments do not appear to contribute to developmental delays in children 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Key Facts 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Deals By Therapy Area, 2011 to YTD 2017 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cyprium Therapeutics Enters into Research and Development Agreement with Eunice Kennedy Shriver NICHD 10
SRI International Enters into Biological Testing Facility Contract with NICHD 11
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 12
NICHD Enters into Licensing Agreement with Cyprium Therapeutics 13
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Key Competitors 14
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Key Employees 15
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Subsidiaries 16